Results 11 to 20 of about 41 (35)

Investigations of guayule resin as a wood protectant [PDF]

open access: yes
Wood products are subject to deterioration by numerous processes, as a biological material. Today, a significant area of preservative development is the utilization of existing plant residues that have water-repelling, antibacterial, antifungal, and ...
Aguma, Queen
core   +1 more source

Microbial transformation of argentatins by Cunninghamella elegans

open access: yes
Microbial biotransformation of argentatin A (1), isoargentatin A (2) and argentatin B (3), the cycloartane- and lanostane-type triterpenoid constituents of guayule (Parthenium argentatum) resin, with Cunninghamella elegans ATCC 9245-A0 afforded eight new
Gunatilaka, A. A.Leslie   +5 more
core   +1 more source

Composition of Guayule (Parthenium argentatum Gray) resin. [PDF]

open access: yesSci Rep, 2023
Rousset A   +7 more
europepmc   +1 more source

Argentatin Content in Guayule Leaves (Parthenium argentatum A. Gray). [PDF]

open access: yesPlants (Basel), 2023
García-Martínez MM   +6 more
europepmc   +1 more source

Argentatin C Analogues with Potential Antinociceptive Activity and Other Triterpenoid Constituents from the Aerial Parts of <i>Parthenium incanum</i>. [PDF]

open access: yesACS Omega, 2023
Xu YM   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera   +2 more
exaly  

Home - About - Disclaimer - Privacy